Abstract

Any human enterprise that consumes billions of dollars, especially when those dollars are those of citizen tax payers, should be subject to at least occasional scrutiny and stock-taking. This Special Issue of Perspectives in Biology and Medicine is an attempt to do just that: to ask whether the massive investment of money, equipment and human scientific talent that has been poured into studying the human genome under the assumption that this enormous scientific endeavor will advance human health has been worth it thus far, and whether it is likely to bear fruit in the futureThe expression that best encapsulates the goal of using genomic information to alter trajectories of...